Notice Type
Departmental
Notice Title

Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Crystaderm
Active Ingredient: Hydrogen peroxide 1%w/w
Dosage Form: Topical cream
New Zealand Sponsor: HMA Research Limited
Manufacturer: Bioglan AB, Malmo, Sweden
Product: Letrole
Active Ingredient: Letrozole 2.5mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Mylan Pharmaceuticals ULC Oncology, Ontario, Canada
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 25µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories (Puerto Rico) Inc., Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 50µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories (Puerto Rico) Inc., Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 75µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories (Puerto Rico) Inc., Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 88µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories (Puerto Rico) Inc., Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 100µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories (Puerto Rico) Inc., Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 112µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories (Puerto Rico) Inc., Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 125µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories (Puerto Rico) Inc., Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 137µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories (Puerto Rico) Inc., Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 175µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories (Puerto Rico) Inc., Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 150µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories (Puerto Rico) Inc., Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 200µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories (Puerto Rico) Inc., Puerto Rico, United States of America
Product: Synthroid
Active Ingredient: Levothyroxine sodium, anhydrous 300µg
Dosage Form: Tablet
New Zealand Sponsor: Abbott Laboratories (NZ) Limited
Manufacturer: Abbott Laboratories (Puerto Rico) Inc., Puerto Rico, United States of America
Dated this 25th day of March 2010.
ANTHONY HILL, Deputy Director-General, Regulation and Governance Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).